Publications

For theses done in our group, visit here.

2020

2019

2018

  • Villa A, Klein B, Janssen B, Pedragosa J, Pepe G, Zinnhardt B, Vugts D J, Gelosa P, Sironi L, Beaino W, Damont A, Dollé F, Jego B, Winkeler A, Ory D, Solin O, Vercouillie J, Funke U, Laner-Plamberger S, Blomster L V, Christophersen P, Vegeto E, Aigner L, Jacobs A, Planas A, Maggi A, Windhorst A D, Identification of New Molecular Targets for PET Imaging of the Microglial Anti-Inflammatory Activation State. Theranostics 8(19) (2018) 5400-18. (IF=9.009)
  • Keller T, López-Picón FR, Krzyczmonik A, Forsback S, Kirjavainen AK, Takkinen JS, Al-Zghool O, Rajander J, Teperi S, Cacheux F, Damont A, Dollé F, Rinne JO, Solin O, Haaparanta-Solin M, [18F]F-DPA for the Detection of Activated Microglia in a Mouse Model of Alzheimer’s Disease. Nucl Med Biol. 67 (2018) 1-9. (IF=2.186)
  • Savisto N, Bergman J, Aromaa J, Forsback S, Eskola O, Viljanen T, Rajander J, Johansson S, Grigg J, Luthra S, Solin O. Influence of transport line material on the molar activity of cyclotron produced [18F]fluoride. Nucl Med Biol. 64-65 (2018) 8-15. (IF=2.186)
  • Laaksonen L, Kallioinen M, Långsjö J, Laitio T, Scheinin A, Scheinin J, Kaisti K, Maksimow A, Kallionpää RE, Rajala V, Johansson J, Kantonen O, Nyman M, Sirén S, Valli K, Revonsuo A, Solin O, Vahlberg T, Alkire M, Scheinin H. Comparative effects of dexmedetomidine, propofol, sevoflurane, and S-ketamine on regional cerebral glucose metabolism in humans: a positron emission tomography study. Br J Anaesth. 121 (2018) 281-90. (IF=6.371)
  • U Din M, Saari T, Raiko J, Kudomi N, Maurer SF, Lahesmaa M, Fromme T, Amri EZ, Klingenspor M, Solin O, Nuutila P, Virtanen KA. Postprandial Oxidative Metabolism of Human Brown Fat Indicates Thermogenesis. Cell Metab. 28 (2018) 207-16. (IF=21.398)
  • Takkinen JS, López-Picón FR, Kirjavainen AK, Pihlaja R, Snellman A, Ishizu T, Löyttyniemi E, Solin O, Rinne JO, Haaparanta-Solin M. [18F]FMPEP-d2 PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer’s disease. Neurobiol Aging. 69 (2018) 199-208. (IF=5.060)
  • Tolmachev V, Grönroos TJ, Yim CB, Garousi J, Yue Y, Grimm S, Rajander J, Perols A, Haaparanta-Solin M, Solin O, Ferdani R, Orlova A, Anderson CJ, Karlström AE. Molecular design of radiocopper-labelled Affibody molecules. Sci Rep. 8 (2018) 6542. (IF=4.609)
  • Leinonen V, Rauramaa T, Johansson J, Bottelbergs A, Tesseur I, van der Ark P, Pemberton D, Koivisto AM, Jääskeläinen JE, Hiltunen M, Herukka SK, Blennow K, Zetterberg H, Jokinen P, Rokka J, Helin S, Haaparanta-Solin M, Solin O, Okamura N, Kolb HC, Rinne JO. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies. J Alzheimers Dis. 64 (2018) 171-9. (IF=3.792)
  • Savisto N, Viljanen T, Kokkomäki E, Bergman J, Solin O. Automated production of [18F]FTHA according to GMP. J Labelled Comp Radiopharm. 61 (2018) 84-93. (IF=1.367)
  • Sjöros TJ, Heiskanen MA, Motiani KK, Löyttyniemi E, Eskelinen JJ, Virtanen KA, Savisto NJ, Solin O, Hannukainen JC, Kalliokoski KK. Increased insulin-stimulated glucose uptake in both leg and arm muscles after sprint interval and moderate-intensity training in subjects with type 2 diabetes or prediabetes. Scand J Med Sci Sports. 28 (2018) 77-87. (IF=3.668)
  • Kirjavainen AK, Forsback S, López-Picón FR, Marjamäki P, Takkinen J, Haaparanta-Solin M, Peters D, Solin O. 18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation. Nucl Med Biol. 56 (2018) 39-46. (IF=2.186)
  • Silvoniemi A, Suilamo S, Laitinen T, Forsback S, Löyttyniemi E, Vaittinen S, Saunavaara V, Solin O, Grönroos TJ, Minn H. Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer. Eur J Nucl Med Mol Imaging. 45 (2018) 161-9. (IF=6.553)
  • López-Picón FR, Snellman A, Eskola O, Helin S, Solin O, Haaparanta-Solin M, Rinne JO Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease. J Nucl Med. 59 (2018) 509-15.(IF=6.893)

2017

  • Kryzmonik A., Keller T., Kirjavainen AK., Lahdenpohja S., Forsback S., Solin O., Use of SF6 for the production of electrophilic 18F-fluorination reagents, J Fluor Chem. 204 (2017) 90-7. (IF=1.862)
  • Rokka J, Grönroos TJ, Viljanen T, Solin O, Haaparanta-Solin M. HPLC and TLC methods for analysis of [18F]FDG and its metabolites from biological samples. J Chromatogr B Analyt Technol Biomed Life Sci. 1048 (2017) 140-9. (IF=2.526)
  • Tolmachev V., Yim C-B., Rajander J., Perols A., Eriksson Karlström A., Haaparanta-Solin M., Grönroos TJ., Solin O., Orlova A. Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA. Contrast Media & Molecular Imaging. (2017), Article ID 8565802, https://doi.org/10.1155/2017/8565802 (IF=2.701)
  • Snellman A., Rokka J., López-Picón FR., Helin S., Re F., Löyttyniemi E., Pihlaja R., Forloni G., Salmona M., Masserini M., Solin O., Rinne JO., Haaparanta-Solin M., Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model. Neurobiol Aging. 57 (2017) 84-94. (IF=5.060)
  • Motiani KK., Savolainen AM., Eskelinen JJ., Toivanen J., Ishizu T., Yli-Karjanmaa M., Virtanen KA., Parkkola R., Kapanen J., Grönroos TJ., Haaparanta-Solin M., Solin O., Savisto N., Ahotupa M., Löyttyniemi E., Knuuti J., Nuutila P., Kalliokoski KK., Hannukainen JC. Two weeks of moderate-intensity continuous training, but not high-intensity interval training, increases insulin-stimulated intestinal glucose uptake. J Appl Physiol. 122 (2017) 1188-97 (IF=3.465)
  • Krzyczmonik A., Keller T., Kirjavainen AK., Forsback S, Solin O. Vacuum ultraviolet photon-mediated production of [18F]F2. J Labelled Comp Radiopharm. 60 (2017) 186-93 (IF=1.367)
  • Din MU., Raiko J., Saari T., Saunavaara V., Kudomi N., Solin O., Parkkola R., Nuutila P., Virtanen KA. Human brown fat radiodensity indicates underlying tissue composition and systemic metabolic health. J Clin Endocrinol Metab. 102 (2017) 2258–67 (IF=6.011)
  • Keller T., Krzyczmonik A., Forsback S., Picón FR., Kirjavainen AK., Takkinen J., Rajander J., Cacheux F., Damont A., Dollé F., Rinne JO., Haaparanta-Solin M., Solin O. Radiosynthesis and Preclinical Evaluation of [18F]F-DPA, A Novel Pyrazolo[1,5a]pyrimidine Acetamide TSPO Radioligand, in Healthy Sprague Dawley Rats. Mol Imaging Biol. 19 (2017) 736–45 (IF=2.900)
  • Takkinen JS., López-Picón FR., Al Majidi R, Eskola O, Krzyczmonik A, Keller T, Löyttyniemi E, Solin O, Rinne JO, Haaparanta-Solin M, Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging. J Cereb Blood Flow Metab. 37 (2017) 2870-82(IF=6.030)

2016

  • Mikkola K., Yim CB., Lehtiniemi P., Kauhanen S., Tarkia M., Tolvanen T., Nuutila P., Solin O. Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, 18F-labeled [Nle14,Lys40]exendin-4 analog, shows promise for clinical imaging.  EJNMMI Res. 6 (2016) 91 (IF=2.376)
  • Liu H, Audisio D, Plougastel L, Decuypere E, Buisson DA, Koniev O, Kolodych S, Wagner A, Elhabiri M, Krzyczmonik A, Forsback S, Solin O, Gouverneur V, Taran F. Ultrafast Click Chemistry with Fluorosydnones. Angew Chem Int Ed Engl. 55 (2016) 12073–77 (IF=11.838) HOT PAPER
  • Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Te Beek ET, Groeneveld GJ, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne J. Parametric binding images of the TSPO ligand [18F]DPA-714. J Nucl Med. 57 (2016) 1543-7. (IF=6.459)
  • Jadhav S, Yim CB, Rajander J, Grönroos TJ, Solin O, Virta P. Solid-Supported Porphyrins Useful for the Synthesis of Conjugates with Oligomeric Biomolecules. Bioconjug Chem. 27 (2016) 1023-9 (IF= 4.574)
  • Rokka J, Snellman A, Kaasalainen M, Salonen J, Zona C, La Ferla B, Nicotra F, Re F, Masserini M, Forsback S, Lopez-Picon F, Rinne JO, Haaparanta-Solin M, Solin O, 18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer’s disease. Eur J Pharm Sci. 88 (2016) 257-66 (IF=3.866)
  • López-Picón F, Snellman A, Shatillo O, Lehtiniemi P, Grönroos TJ, Marjamäki P, Trigg W, Jones PA, Solin O, Pitkänen A, Haaparanta-Solin M. Ex vivo tracing of NMDA and GABA-A receptors in rat brain after traumatic brain injury using 18F-GE-179 and 18F-GE-194 autoradiography, J Nucl Med. 57 (2016) 1442-7 (IF=6.459)
  • van Dijk LK, Yim CB, Franssen GM, Kaanders JH, Rajander J, Solin O, Grönroos TJ, Boerman OC, Bussink J. PET of EGFR with Cu-64-cetuximab-F(ab’)(2) in mice with head and neck squamous cell carcinoma xenografts. Contrast Media Mol Imaging. 11 (2016) 65-70 (IF=2.760)

2015

  • Buckingham F, Kirjavainen AK, Forsback S, Krzyczmonik A, Keller T, Newington IM, Glaser M, Luthra SK, Solin O, Gouverneur V, Organomediated Enantioselective 18F Fluorination for PET Applications. Angew Chem Int Ed Engl. 54(2015) 13366-9 (IF=11.838)
  • Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S., Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, Vollmer S, Dyrks T, Lehmann L, Heinrich T, Hoffmann A, Nordberg A, Halldin C, Rinne JO, Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects. Eur J Nucl Med Mol Imaging. 42 (2015) 438-46 (IF=6.218)
  • Airas L, Dickens AM, Elo P, Marjamäki P, Johansson J, Eskola O, Jones PA, Trigg W, Solin O, Haaparanta-Solin M, Anthony DC, Rinne JO, In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis. J Nucl Med. 56 (2015) 305-10 (IF=6.459)
  • Forsback S, Solin O, Post-target produced [18F]F2 in the production of PET radiopharmaceuticals, Radiochimica Acta 103 (2015) 219-26 (IF=1.229)
  • Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer’s disease patients. J Cereb Blood Flow Metab. 35 (2015) 766-72 (IF=5.479)
  • Eriksson O, Mikkola K, Espes D, Tuominen L, Virtanen K, Forsbäck S, Haaparanta-Solin M, Hietala J, Solin O, Nuutila P. The Cannabinoid Receptor-1 is an imaging biomarker of Brown Adipose Tissue. J Nucl Med. 56 (2015) 1937-41 (IF=6.459)
  • Finnema SJ, Hughes ZA, Haaparanta-Solin M, Stepanov V, Nakao R, Varnäs K, Varrone A, Arponen E, Marjamäki P, Pohjanoksa K, Vuorilehto L, Babalola PA, Solin O, Grimwood S, Sallinen J, Farde L, Scheinin M, Halldin C. Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain. Int J Neuropsychopharmacol. 18 (2015) 1-10 (IF=4.45)

2014

  • Mikkola K, Yim C-B, Fagerholm V, Ishizu T, Elomaa V-V, Rajander J, Jurttila J, Saanijoki T, Tolvanen T, Tirri M, Gourni E, Behe M, Gotthardt M, Reubi JC, Macke H, Roivainen A, Solin O, Nuutila P, 64Cu- and 68Ga-labelled [Nle14,Lys40(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats,  Mol Imaging Biol. 16 (2014) 255-63 (IF=2.467)
  • Arponen E, Helin S, Marjamäki P, Grönroos T, Holm P, Löyttyniemi E, Någren K, Scheinin M, Haaparanta-Solin M, Sallinen J, Solin O, A PET Tracer for Brain α2C Adrenoceptors, 11C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice, J Nucl Med., 55 (2014) 1171-7 (IF=6.459)
  • Grönroos T.J., Lehtiö K., Söderström K.O., Kronqvist P., Laine J., Eskola O., Viljanen T., Grénman R., Solin O., Minn H., Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET. BMC Cancer. 14 (2014) 876 (IF=3.642)
  • Komar G., Lehtiö K., Seppänen M., Eskola O., Levola H., Lindholm P., Sipilä H., Seppälä J., Grénman R., Solin O., Minn H.,Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy. Eur J Nucl Med Mol Imaging. 41, (2014) 2042-50 (IF=6.218)
  • Silén J., Högel H., Kivinen K., Silvoniemi A., Forsback S., Löyttyniemi E., Solin O., Grénman R., Minn H., Jaakkola P.M., Grönroos T.J., Uptake of [18F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma., Transl Oncol. 7 (2014) 403-11 (IF=3.085)
  • Rokka J, Snellman A, Zona C., La Ferla B, Nicotra F, Salmona M, Forloni G, Haaparanta-Solin M, Rinne JO, Solin O, Synthesis and evaluation of a [18F]curcumin derivate for β-amyloid plaque imaging. Bioorg Med Chem. 22 (2014) 2753-62 (IF=2.303)
  • Elomaa VV, Jurttila J, Rajander J, Solin O, Automation of 64Cu production at Turku PET Centre. Appl Radiat Isot. 89 (2014) 74-8 (IF=1.125)
  • Dickens AM, Vainio S, Marjamäki P, Johansson J, Lehtiniemi P, Rokka J, Rinne J, Solin O, Haaparanta-Solin M, Jones PA, Trigg W, Anthony DC., Airas L, Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med. 55 (2014) 466-72 (IF=6.459)
  • Rinne JO, Frantzen J, Leinonen V, Lonnrot K, Laakso A, Virtanen KA, Solin O, Kotkansalo A, Koivisto A, Sajanti J, Karppinen A, Lehto H, Rummukainen J, Buckley C, Smith A, Jones PA, Sherwin P, Farrar G, McLain R, Kailajarvi M, Grachev ID, Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus. Neurodegener Dis. 13 (2014) 237-45. (IF=2.716)
  • Kalliokoski T., Tuomela J., Haavisto L., Forsback S., Snellman A., Helin S., Grönroos T.J., Solin O., Haaparanta-Solin M., 6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism. Mol Imaging Biol. 16 (2014) 403-11. (IF=2.467)
  • Silvoniemi A., Silén J., Forsback S., Löyttyniemi E., Schrey A.R., Solin O., Grénman R., Minn H., Grönroos T.J., Evaluation of repeated [18F]EF5 PET/CT-scans and tumor growth rate in experimental head and neck carcinoma, EJNMMI Res. 4 (2014) 65. (IF=2.376)
  • Snellman A, Rokka J, López-Picón FR, Eskola O, Salmona M, Forloni G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M. In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer’s disease with a high specific activity PET imaging agent [18F]flutemetamol. EJNMMI Res. 4 (2014) 37. (IF=2.376)

2013

  • Thieme S, Walther M, Preusche S, Rajander J, Pietzsch HJ, Lill JO, Kaden M, Solin O, Steinbach, High specific activity 61Cu via 64Zn(p,α)61Cu reaction at low proton energies. Appl Radiat Isot. 73 (2013) 169-76. (IF=1.125)
  • Tuomela J, Forsback S, Haavisto L, Vahlberg T, Grönroos TJ, Solin O, Haaparanta-Solin M., Enzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma. EJNMMI Res. 3 (2013). (IF=2.376)
  • Kirjavainen A, Forsback S, Grönroos TJ, Haavisto L, Haaparanta M, Solin O, Electrophilic Addition of Chlorine Monofluoride for PET tracers, Mol Imaging Biol. 15 (2013) 131-5. (IF=2.467)
  • Rokka J., Federico C., Jurttila J., Snellman A., Haaparanta M., Rinne J.O., Solin O., 19F/18F exchange synthesis for a novel [18F]S1P3 –radiopharmaceutical, J Label Comp Radiopharm 56 (2013) 385-91 (IF=1.263)
  • Stenhagen IS, Kirjavainen AK, Forsback SJ, Jørgensen CG, Robins EG, Luthra SK, Solin O, Gouverneur V., [18F]Fluorination of an arylboronic ester using [18F]selectfluor bis(triflate): application to 6-[18F]fluoro-l-DOPA, Chem Commun (Camb). 49 (2013) 1386-8 (IF=6.628)
  • Snellman A., López-Picón F.R., Rokka J., Salmona M., Forloni G., Scheinin M., Solin O., Rinne J.O. and Haaparanta-Solin M., Longitudinal amyloid imaging in mouse brain with [11C]PIB — comparison of APP23, Tg2576 and APPswe-PS1dE9 mouse models of Alzheimer’s disease, J Nucl Med 54 (2013) 1434-41. (IF=6.459)
  • Mizuta S., Stenhagen I.S., O’Duill M., Wolstenhulme J., Kirjavainen A.K., Forsback S.J., Tredwell M., Sandford G., Moore P.R., Huiban M., Luthra S.K., Passchier J., Solin O., Gouverneur V., Catalytic Decarboxylative Fluorination for the Synthesis of Tri- and Difluoromethyl Arenes. Org Lett. 15 (2013) 2648-51 (IF=5.849)
  • Yim CB, Mikkola K, Fagerholm V, Elomaa VV, Ishizu T, Rajander J, Schlesinger J, Roivainen A, Nuutila P, Solin O. Synthesis and preclinical characterization of [64Cu]NODAGA-MAL-exendin-4 with a Nε-maleoyl-l-lysyl-glycine linkage. Nucl Med Biol. 40 (2013) 1006-12 (IF=2.299)

2012-1980

  • Eskola O, Grönroos TJ, Naum A, Marjamäki P, Forsback S, Bergman J, Länkimäki S, Kiss J, Savunen T, Knuuti J, Haaparanta M, Solin O, Novel electrophilic synthesis of 6-[18F]fluorodopamine and comphrehensive biological evaluation, Eur J Nucl Med Mol Imaging 39 (2012) 800-10.
  • Forsback S, Marjamäki P, Eskola O, Bergman J, Rokka J, Grönroos T, Haaparanta M, Solin O, [18F]CFT synthesis and binding to monoamine transporters in rats, EJNMMI Research. 2 (2012).
  • Snellman A, Rokka J, Lopez-Picon FR, Eskola O, Wilson I, Farrar G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M, Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer’s disease, Eur J Nucl Med Mol Imaging. 39 (2012) 1784-95.
  • Lin LL, Silvoniemi A, Stubbs JB, Rengan R, Suilamo S, Solin O, Divgi C, Eskola O, Sorger JM, Stabin MG, Kachur A, Hahn SM, Grönroos TJ, Forsback S, Evans SM, Koch CJ, Minn H., Radiation Dosimetry and Biodistribution of the Hypoxia Tracer [18F]EF5 in Oncologic Patients, Cancer Biother Radiopharm. 27 (2012) 412-9.
  • Li X-G, Haaparanta M, Solin O, Oxime formation for fluorine-18 labeling of peptides and proteins for positron emission tomography (PET) imaging: A review, J. Fluor Chem. 143 (2012) 49-56.
  • Schlesinger Joern, Rajander Johan, Ihalainen Janne A, Ramesh D, Eklund P, Fagerholm V, Nuutila P, Solin O, Isomerism of [64Cu-NOTA-Bn]-Labeled Radiotracers: Separation of Two Complex Isomers and Determination of Their Interconversion Energy Barrier Using Ion Pair Chromatography , Inorganic Chemistry 50 (2011) 4260-71.
  • Eskola O, Grönroos TJ, Forsback S, Tuomela J, Komar G, Bergman J, Härkönen P, Haaparanta M, Minn H, Solin O, Tracer Level Electrophilic Synthesis and Pharmacokinetics of the Hypoxia Tracer [18F]EF5. Mol Imaging Biol. 14 (2011) 205-12.
  • Marjamäki P, Haaparanta M, Forsback S, Fagerholm V, Eskola O, Grönroos T, Koivula T, Solin O, Comparison of 2β-carbomethoxy-3β-(4-[18F]fluorophenyl)tropane and N-(3-[18F]fluoropropyl)-2β-carbomethoxy-3β-(4-fluorophenyl)nortropane, Tracers for Imaging Dopamine Transporter in Rat, Mol Imaging Biol 12(2010) 269-77.
  • Karmi A, Iozzo P, Viljanen A, Hirvonen J, Fielding BA, Virtanen K, Oikonen V, Kemppainen J, Viljanen T, Guiducci L, Haaparanta-Solin M, Någren K, Solin O, Nuutila P., Increased brain Fatty Acid uptake in metabolic syndrome. Diabetes 59 (2010) 2171-7.
  • Fagerholm V, Mikkola KK, Ishizu T, Arponen E, Kauhanen S, Någren K, Solin O, Nuutila P, Haaparanta M., Assessment of Islet Specificity of Dihydrotetrabenazine Radiotracer Binding in Rat Pancreas and Human Pancreas. J Nucl Med 51 (2010) 1439-46.
  • Teare H, Robins EG, Kirjavainen A, Forsback S, Sandford G, Solin O, Luthra SK, Gouverneur V., Radiosynthesis and Evaluation of [18F]Selectfluor bis(triflate), Angew Chem Int Ed Engl 49 (2010) 6821-24. HOT PAPER
  • Koivula T., Laine J., Lipponen T., Perhola O., Kämäräinen E-L., Bergström K., Solin O., Assessment of labelled products with different radioanalytical methods: study on 18F-fluorination reaction of 4-[18F]fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-2-pyridinyl-benzamide (p-[18F]MPPF), J Radioanal Nucl Ch (2010) 841-6.
  • Tuomela J, Grönroos T, Valta M,  Sandholm J, Schrey A, Seppänen J, Marjamäki P, Forsback S, Kinnunen I, Solin O, Minn H, Härkönen P, Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts, BMC Cancer 596 (2010)
  • Forsback S, Eskola O, Bergman J, Haaparanta M, Solin O, Alternative solvents for electrophilic synthesis of 6-[F-18]fluoro-L-DOPA, J Label Comp Radiopharm 52 (2009) 286-8.
  • Menichetti L, Cionini L, Sauerwein WA, Altieri S, Solin O, Minn H, Salvadori PA, Positron emission tomography and [F-18]BPA: A perspective application to assess tumour extraction of boron in BNCT, Appl Radiat Isot 67 (2009) S351-4.
  • Avila-Rodriguez MA, Rajander J, Lill JO, Gagnon K, Schlesinger J, Wilson JS, McQuarrie, Solin O, Proton energy determination using activated yttrium foils and ionization chambers for activity assay, Nucl Instr Meth B 267 (2009) 1867-72.
  • Tárkányi F, Takács S, Király B, Szelecsényi F, Andó L, Bergman J, Heselius SJ, Solin O, Hermanne A, Shubin YN, Ignatyuk AV, Excitation functions of He-3- and alpha-particle induced nuclear reactions on Sb-nat for production of medically relevant I-123 and I-124 radioisotopes, Appl Radiat Isot 67 (2009) 1001-6.
  • Huttunen J, Heinimaa M, Svirskis T, Nyman M, Kajander J, Forsback S, Solin O, Ilonen T, Korkeila J, Ristikari T, McGlashan T, Salokangas RK, Hietala J. Striatal Dopamine Synthesis in First-degree Relatives of Patients with Schizophrenia. Biol Psychiatry 63 (2008) 114-7.
  • Koivula T, Marjamäki P, Haaparanta M, Fagerholm V, Lipponen T, Grönroos T, Perhola O, Vepsäläinen J, Solin O. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2ß-carbomethoxy-3ß-(4-fluorophenyl)nortropane ([18F]ß-CFT-FP) in rats, Nucl Med Biol 35 (2008) 177-83.
  • Forsback S, Eskola O, Haaparanta-Solin M, Bergman J, Solin O, Electrophilic synthesis of 6-[18F]Fluoro-L-dopa using post-target produced [18F]F2 , Radiochimica Acta 96 (2008) 845-8.
  • Minn H, Grönroos T, Komar G, Eskola O, Lehtiö K, Tuomela J, Seppänen M, Solin O, Imaging of Tumor Hypoxia to Predict Treatment Sensitivity, Curr Pharm Design 14 (2008) 2932-42.
  • Komar G, Seppänen M, Eskola O, Lindholm P, Grönroos T, Forsback S, Sipilä H, Evans SM, Solin O, Minn H, [18F]EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer, J Nucl Med 49 (2008) 1944-51.
  • Kauhanen S, Seppanen M, Minn H, Gullichsen R, Salonen A, Alanen K, Parkkola R, Solin O, Bergman J, Sane T, Salmi J, Valimaki M, Nuutila P. Fluorine-18-L-dihydroxyphenylalanine (F-18-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrin Metab 92 (2007)1237-44.
  • Nyman MJ, Eskola O, Kajander J, Vahlberg T, Sanabria S, Burns D, Hargreaves R, Solin O, Hietala J. Gender and age affect NK1 receptors in the human brain – a positron emission tomography study with [F-18]SPA-RQ. Int J Neuropsychopharm 10 (2007) 219-29.
  • Kamarainen EL, Haaparanta M, Siitari-Kauppi M, Koivula T, Lipponen T, Solin O. Analysis of 18F-labelled synthesis products on TLC plates: comparison of radioactivity scanning, film autoradiography, and a phosphoimaging technique. Appl Radiat Isot 64 (2006) 1043-7.
  • Haaparanta M, Gronroos T, Eskola O, Bergman J, Solin O. Planar chromatographic analysis and quantification of short-lived radioactive metabolites from microdialysis fractions. J Chromatogr A 1108 (2006) 136-9.
  • Koivula T, Perhola O, Kamarainen EL, Lipponen T, Vepsalainen J and Solin O, Simplified synthesis of N-(3-[F-18]fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane ([F-18]beta-CFT-FP) using [F-18]fluoropropyl tosylate as the labelling reagent, J Label Comp Radiopharm 48 (2005) 463-71.
  • Hietala J, Nyman MJ, Eskola O, Laakso A, Gronroos T, Oikonen V, Bergman J, Haaparanta M, Forsback S, Marjamaki P, Lehikoinen P, Goldberg M, Burns D, Hamill T, Eng WS, Coimbra A, Hargreaves R and Solin O. Visualization and Quantification of Neurokinin-1 (NK1) Receptors in the Human Brain. Mol Imaging Biol (2005) 262-72.
  • Kalliokoski T, Simell O, Haaparanta M, Viljanen T, Solin O, Knuuti J, Nuutila P. An autoradiographic study of [18F]FDG uptake to islets of Langerhans in NOD mouse. Diabetes Res Clin Pract 70 (2005) 217-24.
  • Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O, Syvalahti E, Hietala J. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15 (2005) 387-91.
  • Forsback S, Niemi R, Marjamäki P, Eskola O, Bergman J, Grönroos T, Haaparanta M, Haapalinna A, Rinne J and Solin O, Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson’s disease, Synapse 51 (2004) 119-127, IF 2.524
  • Kämäräinen E, Kyllönen T, Nihtilä O, Björk H and Solin O, Preparation of fluorine-18-labelled fluoromisonidazole using two different synthesis methods, J Labelled Comp Radiopharm 47 (2004) 37-45.
  • Eskola O, Grönroos T, Bergman J, Haaparanta M, Marjamäki P, Lehikoinen P, Forsback S, Dollé F, Langer O, Halldin C and Solin O, A novel electrophilic synthesis and evaluation of medium specific radioactivity (1R,2S)-4-[18F]fluorometaraminol, a tracer for the assesment of cardiac symphatetic nerve integrity with PET, Nucl Med Biol 31 (2004) 103-110.
  • Grönroos T, Benzen L, Marjamäki P, Murata R, Horsman MR, Keiding S, Eskola O, Haaparanta M, Minn H and and Solin O, Comparision of biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma, Eur J Nucl Med Mol Imaging 31 (2004) 513-20.
  • Haaparanta M, Grönroos T, Marjamäki P, Eskola O, Bergman J, Paul R and Solin O, In vivo sampling for pharmacokinetic studies in small experimental animals: a combination of microdialysis, planar chromatography and digital autoradiography, Mol Imaging Biol 6 (2004) 27-33, IF 2.951
  • Hällsten U, Lindblom P and Solin O, Oxygen reactions in high-pressure nitrogen gas studied with optical emission spectroscopy, Appl Radiat Isot 60 (2004) 787-92.
  • Hällsten U and Solin O, A method for calculating the energy distribution and yield of electrons ejected by protons in Nitrogen gas targets, Nucl Instr Meth B 222 (2004) 421-31.
  • Bergstrom M, Hargreaves RJ, Burns D, Goldberg MR, Petty KJ, Ögren M, Antoni G, Långström B, Eskola O, Scheinin M, Solin O, Majumdar AK, Constanzer ML, Battisti WP, Bradstreet TE, Gargano C, and Hietala J, Human Positron Emission Tomography Studies of Brain Neurokinin 1 Receptor Occupancy by Aprepitant, Biol Psychiatry 55 (2004) 1007-12.
  • Solin O, Eskola O, Hamill T.G., Bergman J, Lehikoinen P, Grönroos T, Forsback S., Haaparanta M., Viljanen T., Ryan C., Gibson R., Kieczykowski G., Hietala J., Hargreaves R. and Burns H.D. Synthesis of and characterisation of a potent, selective, radiolabeled substance-P antagonist (SPA) for NK1 receptor quantitation: ([18F]SPA-RQ). Mol Imaging Biol 6 (2004) 373-84.
  • Marjamäki P, Zessin J, Eskola O, Grönroos T, Haaparanta M, Bergman J, Lehikoinen P, Forsback S, Brust P, Steinbach J and Solin O, S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: Evaluation in rats, Synapse 47 (2003) 45-53.
  • Brust P, Zessin J, Kuwabara H, Pawelke B, Kretzschmar M, Hinz R, Bergman J, Eskola O, Solin O, Steinbach J and Johannsen B. Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652, Synapse 47 (2003) 143-51.
  • Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO, Progression of dopaminergic hypofunction in striatal subregions in Parkinson’s disease using [18F]CFT PET, Synapse 48 (2003) 109-15.
  • Laakso A, Wallius E, Kajander J, Bergman J, Eskola O, Solin O, Ilonen T, Salokangas RK, Syvälahti E, Hietala J, Personality traits and striatal dopamine synthesis capacity in healthy subjects, Am J Psychiatry 160 (2003) 904-10.
  • Iozzo P, Hällsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P, Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control, J Clin Endocrinol Metab 88 (2003) 2055-60.
  • Iozzo P, Geisler F, Oikonen V, Mäki M, Takala T, Solin O, Ferrannini E, Knuuti J, Nuutila P, 18F-FDG PET Study., Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study, J Nucl Med 44 (2003) 682-9.
  • Iozzo P, Turpeinen AK, Takala T, Oikonen V, Solin O, Ferrannini E, Nuutila P, Knuuti J, Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET, Eur J Nucl Med Mol Imaging 30 (2003) 1160-4.
  • Iozzo P, Hällsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, Solin O, Lönnqvist F, Ferrannini E, Knuuti J, Nuutila P, Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes, Diabetes Care 26 (2003) 2069-74.
  • Haaparanta M, Paul R, Grönroos T, Bergman J, Kämarainen EL, Solin O, Microdialysis and 2-[18F]fluoro-2-deoxy-D-glucose (FDG): a study on insulin action on FDG transport, uptake and metabolism in rat muscle, liver and adipose tissue, Life Sci 73 (2003) 1437-51.
  • Virtanen KA, Haaparanta M, Grönroos T, Bergman J, Solin O, Rouru J, Nuutila P and Huupponen R., 2-[18F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats, Diabetes Obes Metab. 4 (2002) 60-8.
  • Hällsten U and Solin O, A method for the recording of density reduction in proton beam irradiated high pressure xenon, Nucl Instr Meth in Phys Res B. 187 (2002) 275-80.
  • Eskola O, Bergman J, Lehikoinen P, Haaparanta M, Grönroos T, Forsback S and Solin O, Synthesis of 3-[[4-(4-[F-18] fluorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine, J Label Comp Radiopharm. 45(2002) 687-96.
  • Vähatalo JK, Eskola O, Bergman J, Forsback S, Lehikoinen P, Jääskelainen J and Solin O, Synthesis of 4-dihydroxyboryl-2-[F-18] fluorophenylalanine with relatively high-specific activity, J Label Comp Radiopharm. 45(2002) 697-704.
  • Kaasinen V, Nurmi E, Bergman J, Solin O, Kurki T and Rinne J, Personality traits and striatal 6-[18F]fluoro-L-dopa uptake in healthy elderly subjects, Neurosci Lett. 332 (2002) 61-4.
  • Laakso A, Vilkman H, Bergman J, Haaparanta M, Solin O, Syvalahti E, Salokangas R and Hietala J, Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects, Biol Psychiatry 52 (2002) 759-63.
  • Bergman J, Eskola O, Lehikoinen P and Solin O, Automated synthesis and purification of [18F]bromofluoromethane at high specific radioactivity, Appl Radiat Isot. 54 (2001) 927-33.
  • Ruottinen HM, Niinivirta M, Bergman J, Oikonen V, Solin O, Eskola O, Eronen E, Sonninen P and Rinne UK, Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson’s disease requires prolonged imaging. Synapse 40 (2001) 19-26.
  • Rinne JO ,Nurmi E, Ruottinen HM, Bergman J, Eskola O, Solin O, [18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson’s disease, Synapse 40 (2001) 193-200.
  • Lehtiö K, Oikonen V, Grönroos T, Eskola O, Kalliokoski K, Bergman J, Solin O, Grenman R, Nuutila P and Minn H, Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [15O]H2O and [18F]fluoroerythronitroimidazole PET. J Nucl Med. 42 (2001) 1643-52.
  • Kaasinen V, Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P and Rinne JO, Personality traits and brain dopaminergic function in Parkinson’s disease. Proc Natl Acad Sci U S A. 98 (2001) 13272-7.
  • Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvälahti E and Hietala J, Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res. 52 (2001) 115-20.
  • Zessin J, Eskola O, Brust P, Bergman J, Steinbach J, Lehikoinen P, Solin O and Johannsen B, Synthesis of S-([18F]fluoromethyl)-(+)-McN5652 as a potential PET radioligand for the serotonin transporter. Nucl Med Biol. 28(2001) 857-63.
  • Bruck A, Portin R, Lindell A, Laihinen A, Bergman J, Haaparanta M, Solin O and Rinne JO, Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett. 311 (2001) 81-4.
  • Grönroos T, Eskola O, Lehtiö K, Minn H, Marjamäki P, Bergman J, Haaparanta M, Forsback S and Solin O. Pharmacokinetics of [18F]FETNIM: a potential marker for PET, J Nucl Med. 42 (2001) 1397-404.
  • Nurmi E, Ruottinen HM, Bergman J, Haaparanta M, Solin O, Sonninen P and Rinne JO, Rate of progression in Parkinson’s disease: a 6-[18F]fluoro-L-dopa PET study, Mov Disord. 16 (2001) 608-15.
  • Kaasinen V, Nurmi E, Bruck A, Eskola O, Bergman J, Solin O and Rinne JO. Increased frontal [18F]fluorodopa uptake in early Parkinson’s disease: sex differences in the prefrontal cortex, Brain 124 (2001) 1125-30.
  • Ruottinen HM, Partinen M, Hublin C, Bergman J, Haaparanta M, Solin O and Rinne JO, An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 54 (2000)502-4.
  • Kahkonen M, Metsahonkala L, Minn H, Utriainen T, Korhonen T, Norvasuo-Heila MK, Harila-Saari A, Aarimaa T, Suhonen-Polvi H, Ruotsalainen U, Solin O and Salmi TT, Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia. Cancer 88 (2000)693-700.
  • Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, Räkköläinen V, Syvälahti E and Hietala J, Striatal Dopamine Transporter Binding in Neuroleptic-Naive Patients With Schizophrenia Studied With Positron Emission Tomography. Am J Psychiatry 157 (2000)269-71.
  • Laakso A, Vilkman H, Kajander J, Bergman J, Haaparanta M, Solin O and Hietala J, Prediction of Detached Personality in Healthy Subjects by Low Dopamine Transporter Binding. Am J Psychiatry 157 (2000)290-2.
  • Salokangas RKR, Vilkman H, Ilonen T., Taiminen T, Bergman J, Haaparanta M, Solin O, Alanen A, Syvälahti E, and Hietala J, High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers. Am J Psychiatry 157 (2000)632-4.
  • Nurmi E, Ruottinen HM, Kaasinen V, Bergman J, Haaparanta M, Solin O and Rinne JO, Progression in Parkinson’s disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT. Ann Neurol. 47 (2000)804-8.
  • Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M and Solin O, Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol. 57 (2000)470-5.
  • DeJesus OT, Haaparanta M, Solin O and Nickles RJ, 6-FluoroDOPA Metabolism in Rat Striatum: Time Course of Extracellular Metabolites. Brain Res. 877 (2000)31-6.
  • Lapela M, Eigtved A, Jyrkkio S, Grenman R, Kurki T, Lindholm P, Nuutinen, J, Sutinen E, Solin O, Bjornskov I, Bretlau P, Friberg L, Holm S, Jensen M, Hansen H and Minn H, Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 36 (2000)858-67.
  • Laihinen A, Ruottinen H, Rinne JO, Haaparanta M, Bergman J, Solin O, Koskenvuo M, Marttila R and Rinne UK, Risk for Parkinson’s disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET. J Neurol. 247,Suppl 2(2000)110-3.
  • Nurmi E, Bergman J, Eskola O Solin O, Hinkka SM, Sonninen P and Rinne JO, Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study., J Cerebr Blood F Metab. 11 (2000)1604-9.
  • Rinne JO, Bergman J, Ruottinen H, Haaparanta M, Eronen E, Oikonen V, Sonninen P and Solin O, Striatal uptake of a novel PET ligand, [18F]beta-CFT, is reduced in early Parkinson’s disease. Synapse 31 (1999)119-24.
  • Lamusuo S, Forss N, Ruottinen HM, Bergman J, Makela JP, Mervaala E, Solin O, Rinne JK, Ruotsalainen U, Ylinen A, Vapalahti M, Hari R, Rinne JO, [18F]FDG-PET and whole-scalp MEG localization of epileptogenic cortex. Epilepsia 40 (1999)921-30.
  • Hietala J, Syvalahti E, Vilkman H, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Eronen E, Ruotsalainen U, Salokangas RK, Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res. 35 (1999)41-50.
  • Rinne JO, Ruottinen H, Bergman J, Haaparanta M, Sonninen P and Solin O, Usefulness of a dopamine transporter PET ligand [18F]beta-CFT in assessing disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67 (1999) 737-41.
  • Suhonen-Polvi H, Varho T, Metsahonkala L, Haataja L, Ruotsalainen U, Haaparanta M, Bergman J, Solin O, Aarimaa T, Holopainen I, Vainionpaa L, Manner T, Jaaskelainen S, Renlund M, Sillanpaa M and Aula P, Increased brain glucose utilization in Salla disease (free sialic acid storage disorder). J Nucl Med. 40 (1999)12-8.
  • Aho K, Lindblom P, Olsson T and Solin O, Pressure-dependent decay of the 3p54p configuration in argon excited by alpha-particles and protons, J Phys B: At. Mol. Opt. Phys. 31 (1998) 4191-203.
  • Laine H, Yki-Järvinen H, Kirvelä O, Tolvanen T, Raitakari M, Solin O, Haaparanta M, Knuuti J, Nuutila P. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 101 (1998)1156-62.
  • Tiihonen J, Vilkman H, Räsänen P, Ryynänen O-P, Hakko H, Bergman J, Hämäläinen T, Laakso A, Haaparanta-Solin M, Solin O, Kuoppamäki M, Syvälahti E and Hietala J Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography, Mol Psych., 4 (1998)156-61.
  • Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O and Hietala J, [18F]ß-CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: Characterisation in human subjects. Synapse 28 (1998) 244-50.
  • Tárkányi F, Takács S, Heselius S-J, Solin O and Bergman J, Static and dynamic effects in gas targets used for medical isotope production, Nucl Instr Meth in Phys Res A, 397 (1997)119-24.
  • Bergman J and Solin O, Fluorine-18-labeled fluorine gas for synthesis of tracer molecules, Nucl. Med. Biol. 24 (1997)677-83.
  • Kinnala A, Nuutila P, Ruotsalainen U, Teras M, Bergman J, Haaparanta M, Solin O, Korvenranta H, Äärimaa T, Wegelius U, Kero P, Suhonen-Polvi H, Cerebral metabolic rate for glucose after neonatal hypoglycaemia., Early Hum Dev. 49 (1997)63-72.
  • Lamusuo S, Ruottinen H, Knuuti J, Härkönen R, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jääskeläinen S, Ylinen A, Kälviäinen R, Vapalahti M, Rinne JO, A comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT and [123I]-iomazenil-SPECT in localizing the epileptogenic cortex. J Neurol Neurosurg Psychiatry 63 (1997)743-8.
  • Mäki MT, Haaparanta MT, Luotolahti MS, Nuutila P, Voipio-Pulkki L-M, Bergman JR, Solin OH, Knuuti JH. Fatty acid uptake is preserved in chronically dysfunctional but viable myocardium, Am J Physiol. 273 (Heart Circ Physiol.) 42 (1997)H2473-80.
  • Mäki M, Nuutila P, Laine H, Voipio-Pulkki L-M, Härkönen R, Haaparanta M, Solin O, Knuuti J. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Diabetes 46 (1997)1491-96.
  • Nuutinen JM, Leskinen S, Elomaa I, Minn H, Varpula M, Solin O, Söderström K-O, Joensuu H, Salminen E. Detection of residual tumors in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer 33 (1997)1234-41.
  • Ruottinen HM, Rinne JO, Haaparanta M, Solin O, Bergman J, Oikonen VJ, Järvelä I, Santavuori P. [18F]Fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis. J Neurol Neurosurg Psychiatry 62 (1997)622-5.
  • Ruottinen HM, Rinne JO, Oikonen VJ, Bergman JR, Haaparanta MT, Solin OH, Ruotsalainen UH, Rinne UK. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction, Synapse 27 (1997)336-46.
  • Haaparanta M, Bergman J, Laakso A, Hietala J, Solin O, [18F]ß-CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats. Synapse 23 (1996)321-7.
  • Kinnala A, Suhonen-Polvi H, Äärimaa T, Kero P, Korvenranta H, Ruotsalainen U, bergman J, Haaparanta M, Solin O, Nuutila P, Wegelius U. Cerebral metabolic rate for glucose during the first six months of life: a [18F]FDG positron emission tomography study, Arch Dis Child 74 (1996)F153-7.
  • Mäki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki L-M, Ruotsalainen U, Haaparanta M, Solin O, Hartiala J, Härkönen R, Knuuti J. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 93 (1996)1658-66.
  • Raitakari M, Nuutila P, Ruotsalainen U, Laine H, Teräs M, Iida H, Mäkimattila S, Utriainen T, Oikonen V, Sipilä H, Haaparanta M, Solin O, Wegelius U, Knuuti J, and Yki-Järvinen H: Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle. Studies using [15O]H2O, [18F]fluoro-2-deoxy-D-glucose, and positron emission tomography. Diabetes 45 (1996)1471-7.
  • Ruotsalainen U, Suhonen-Polvi H, Eronen E, Kinnala A, Bergman J, Haaparanta M, Teräs M, Solin O, Wegelius U. Estimated radiation dose to the newborn in FDG-PET studies. J Nucl Med. 37 (1996)387-93.
  • Bergman J, Johnström P, Haaparanta M, Solin O, Duelfer T and Stone- Elander S, Radiolabelling of 2-oxoquazepam with electrophilic 18F prepared from [18F]fluoride. Appl Radiat Isot. 46 (1995)1027-34.
  • Detrói F, Takács S, Tárkányi F, Fenyvesi A, Bergman J, Heselius S-J and Solin O, Investigation of the Charged Particle Nuclear Reactions on Natural Boron for the Purposes of Thin Layer Activation (TLA), Nucl Instr Meth B 103 (1995) 389-92.
  • Haaparanta M, Paul R, Huovinen R, Kujari H, Bergman J, Solin O and Kangas L, Pharmacokinetics and metabolism of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) in mammary tumors of antiestrogen-treated rats, Nucl Med Biol 22 (1995)483-9.
  • Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, Solin O, Kuoppamäki M, Kirvelä M, Ruotsalainen U and Salokangas R K R, Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients, Lancet 346 (1995)1130-1.
  • Lapela M, Leskinen S, Minn H, Lindholm P, Klemi PJ, Söderström K-O, Bergman J, Haaparanta M, Ruotsalainen U, Solin O and Joensuu H, Increased Glucose Metabolism in Untreated Non-Hodgkin`s Lymphoma: A Study with Positron Emission Tomography and Fluorine-18-Fluorodeoxyglucose, Blood 86 (1995)3522-7.
  • Ruottinen HM, Rinne JO, Ruotsalainen UH, Bergman JR, Oikonen VJ, Haaparanta MT, Solin OH, Laihinen AO and Rinne UK, Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson’s disease, J Neural Transm [P-D Sect] 10 (1995)91-106.
  • Suhonen-Polvi H, Ruotsalainen U, Kinnala A, Bergman J, Haaparanta M, Teräs M, Mäkelä P, Solin O and Wegelius U, FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization. J Nucl Med. 36 (1995)1249-54.
  • Nuutila P, Knuuti MJ, Mäki M, Laine H, Ruotsalainen U, Teräs M, Haaparanta M, Solin O, Yki-Järvinen H. Gender and insulin sensitivity in the heart and skeletal muscles. Diabetes 44 (1995)31-6.
  • Nuutila P, Mäki M, Laine H, Knuuti MJ, Ruotsalainen U, Luotolahti M, Haaparanta M, Solin O, Jula A, Koivisto V, Voipio-Pulkki L-M, Yki-Järvinen H. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest. 96 (1995)1003-9.
  • Aho K, Berg L-E, Hällsten U, Lindblom P and Solin O, Observation of dominant emission of the Gaydon-Herman green system in dense nitrogen excited by energetic ions, J Phys B: At Mol Opt Phys. 27 (1994) L525-8.
  • Aho K, Hällsten U, Lindblom P and Solin O, De-excitation processes of atoms in dense gases studied by combining ion beam and laser excitation, Nucl Instr Meth B 88 (1994) 213-7.
  • Berg L-E, Lindblom P, Olsson T, Aho K, Hällsten U and Solin O, Excitation of oxygen and nitrogen in solid krypton and xenon using ion beam irradiation, J Phys B: At Mol Opt Phys. 27 (1994) 5241-50.
  • Szücs Z, Szelecsényi F, Bergman J, Heselius S-J and Solin O, 3He-Induced nuclear reactions on 209Bi at particle energies less than 28 MeV. Production of 209At, Radiochim Acta 65 (1994) 87-91.
  • Nuutila P, Knuuti J, Heinonen OJ, Ruotslainen U, Teräs M, Bergman J, Solin O, Yki-Järvinen H, Voipio-Pulkki L-M, Wegelius U and Koivisto VA, Different alterations in the insulin-stimulated glucose uptake in the athlete’s heart and skeletal muscle, J Clin Invest. 93 (1994) 2267-74.
  • Blomqvist G, Seitz RJ, Sjögren I, Halldin C, Stone-Elander S, Widen L, Solin O and Haaparanta M, Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography, Acta Phys Scand. 151 (1994) 29-43.
  • Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teräs M, Voipio-Pulkki L-M, Haaparanta M, Solin O, Wegelius U and Yki-Järvinen H, Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans, Am J Physiol. 267 (1994) E941-6.
  • Nickles RJ, deJesus OJ, Solin O and Haaparanta-Solin M, A flow-thgrough detector for nanocurie activities encountered in HPLC analysis of PET metabolites, IEEE Trans. Nucl. Sci. 39 (1992) 2316-21.
  • Nickles RJ and Solin O, A Wide-range flexible Gamma Probe, Appl. Radiat. Isot. 43 (1992) 1169-70.
  • Lindblom P, Ohlsson T, Aho K and Solin O, Pressure Dependent Decay of the 2p53p Configuration in Neon Excited by Alpha Particles, J Phys B, At Mol Opt Phys. 25 (1992) 3489-503.
  • Luxen A, Guillaume M, Melega WP, Pike VW, Solin O and Wagner R, Production of 6-[18F]fluoro-L-DOPA and its metabolism in-vivo – a critical review, Nucl Med Biol. 19 (1992) 149-58.
  • Laihinen A, Rinne JO, Rinne UK, Haaparanta M, Ruotsalainen U, Bergman J and Solin O, [18F]-6-Fluorodopa PET scanning in Parkinson’s disease after selective COMT inhibition with nitecapone (OR-462), Neurology 42 (1992) 199-203.
  • Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teräs M, Haaparanta M, Bergman J, Solin O, Voipio-Pulkki L-M., Wegelius U. and Yki-Järvinen H., Glucose-Free Fatty Acid Cycle Operates in Human Heart and Sceletal Muscle in Vivo, J. Clin. Invest., 89 (1992) 1767-74.
  • Lindblom P, Olsson T and Solin O, Laser-enhanced Proportional Gas Scintillations, Nucl. Instr. Meth A. 302 (1991) 113-8.
  • Tarkanyi F, Kovacs Z, Mahunka I, Solin O and Bergman J, Excitation Function of the 35Cl(α,n)38K Reaction Using Gas Targets, Radiochimica Acta 54 (1991) 165-6.
  • Duelfer T, Johnström P, Stone-Erlander S, Holland A, Halldin C, Haaparanta M, Solin O, Bergman J, Steinman M and Sedvall G, The labelling of 2-Oxoquatzepam with electrophilic 18F, J. Labelled. Comp. Radiopharm. 29 (1991) 1223-39.
  • Halldin C, Farde L, Högberg T, Hall H, Ström P, Ohlberg A and Solin O, A Comparative PET-study of Five Carbon-11 or Fluorine-18 Labelled Salicylamides. Preparation and In Vitro Dopamine D2 Receptor Binding, Nucl. Med. Biol. 18 (1991) 871-81.
  • Rinne JO, Laihinen A, Någren K, Bergman J, Solin O, Haaparanta M, Ruotsalainen U and Rinne UK, PET Demonstrates Different Behaviour of Striatal Dopamine D-1 and D-2 Receptors in Early Parkinsons’s Disease, J. Neur Sci Res. 27 (1990) 494-9.
  • Tedroff J, Aquilonius SM, Laihinen A, Rinne U, Hartvig P, Anderson J, Lundqvist H, Haaparanta M, Solin O, Antoni G, Gee A, Ulin J, and Långström B, Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson´s disease measured with positron emission tomography, Acta Neurol Scand. 81(1990)24-30.
  • Paul R, Aho K, Bergman J, Haaparanta M, Kulmala J, Reissel A and Solin O, Imaging of Rats with Mammary Cancer with two 2-deoxy-2-(18F)-fluoro-D-hexoses, Int J Rad Appl Instrum B 16 (1989) 449-53.
  • Solin O, Bergman J, Haaparanta M and Reissel A, Production of 18F from Water Targets, Specific Radioactivity and Anionic Contaminants, Appl Radiat Isot. 39 (1988) 1065-71.
  • Lindblom P and Solin O, Atomic Near-infrared Noble Gas Scintillations I. Optical Spectra, Nucl Instr Meth. A268 (1988) 204-8.
  • Solin O, Kronman D, Lindblom P, Rosengård U and Vuorinen K, Atomic Near-infrared Noble Gas Scintillations II. Application to Particle Beam Intensity Measurement, Nucl Instr Meth. A268 (1988) 209-11.
  • Lindblom P and Solin O, Atomic Near-Infrared Noble Gas Scintillations III. Detection of Aipha Particles, Nucl Instr Meth. A268 (1988) 212-5.
  • d’Argy R, Paul R, Frankenberger L, Stålnacke C-G, Lundquist H, Kangas L, Halldin C, Någren K, Roeda D, Haaparanta M, Solin O and Långström B, Comparative Double-tracer Whole-body Autoradiography : Uptake of 11C-,18F-, and 3H-labelled Compounds in Rat Tumors, Int J Rad Appl Instrum B 15 (1988) 577-85.
  • Beyer G, Pimentel G, Solin O, Heselius S-J, Taka T, Roeda D and Virtanen H, Production of 123I for Medical Use with Small Accelerators, Isotopenpraxis 24 (1988) 297-303.
  • Paul R, Kiuru A, Söderström K-O, Tuominen J, Johansson R, Haaparanta M, Roeda D and Solin O, Organ and Tumor Distribution of (18F)-2-fluoro-2-deoxy-D-glucose in Fasting and Non-fasting Rats, Life Sci 40 (1987) 1609-16.
  • Heselius S-J, Malmborg P, Solin O and Långström B, Studies of Proton Beam Penetration in Nitrogen-gas Targets with Respect to Production and Specific Radioactivity of Carbon-11, Appl Radiat Isot. 38 (1987) 49-57.
  • Paul R, Roeda D, Johansson R, Ahonen A, Haaparanta M, Solin O and Sipilä H, Scintigraphy with (18F)2-fluoro-2-deoxy-D-glucose of Cancer Patients, Int J Rad Appl Instrum B 13 (1986) 7-12.
  • Suolinna E-M, Haaparanta M, Paul R, Härkönen P, Solin O and Sipilä H, Metabolism of 2-(18F)Fluoro-2-deoxyglucose in Tumor-bearing Rats: Chromatographic and Enzymatic Studies, Int J Rad Appl Instrum B 13 (1986) 577-81.
  • Heselius S-J, Mäkelä P, Solin O and Saarni H, An On-Line System for Long-Distance Transport of 15O-Labelled Gases, Nucl Instr Meth. 227 (1984) 576-83.
  • Heselius S-J, Lindblom P, Nyman EM and Solin O, Studies of Emission-Line Profiles from Ion-Excited Neon Gas Targets, Int J Appl Radiat Isot. 35 (1984) 977-80.
  • Paul R, Johansson R, Kiuru A, Illukka T, Talvio T, Roeda D, Solin O, Söderström K-O, Nordman E and Ahonen A, Imaging of Canine Cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further Applications for Cancer Imaging in Man, Nucl Med Comm., 5 (1984) 641-6.
  • Solin O, Counting of Positron- Emitting Radionuclides on Thin Layer Chromatograms, Int J Appl Radiat Isot., 34 (1983) 1653-4.
  • Brenner M, Heselius S-J and Solin O, The Production and Use of Cyclotron Isotopes in Turku, Finland, Radiobiol-Radiother., 24 (1983) 563-8.
  • Heselius S-J, Lindblom P and Solin O, Optical Studies of the Influence of an Intense Ion Beam on High-Pressure Gas Targets, Int J Appl Radiat Isot. 33 (1982) 653-9.
  • Kulmala J, Keinänen M, Markkula A, Heselius S-J and Solin O, Preliminary Biodistribution Studies with a Hybrid Positron Scanner, Eur J Nucl Med. 6 (1981) 561-5.
  • Keinänen M, Kuikka J, Heselius SJ, Suolinna E-M, Solin O, Långström B and Näntö V, Transcapillary Exchange and Distribution of Carbon-11 Labelled Ethanol in the Isolated Perfused Rat Liver, Acta Physiol Scand. 110 (1980) 39-46.
  • Kuikka JT, Keinänen MT, Suolinna E-M and Solin O, Effect of Instantanous Partition Coefficient of Xenon on the Organ Blood Flow Measurements, Phys Med Biol. 25 (1980) 735-9.